main-logo

ICD-10 Code C93.01 | Acute monoblastic/monocytic leukemia, in remission Symptoms, Diagnosis, Billing

Acute monoblastic/monocytic leukemia, in remission is a hematological malignancy characterized by the proliferation of monoblasts or monocytic cells in the bone marrow and peripheral blood. This condition is clinically significant as it requires ongoing monitoring and management to prevent relapse. The ICD-10 Code C93.01 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track treatment outcomes and resource utilization.

What is ICD-10 Code C93.01 for Acute monoblastic/monocytic leukemia, in remission?

ICD-10 Code C93.01 represents Acute monoblastic/monocytic leukemia, in remission, a subtype of acute myeloid leukemia. This code is used when a patient has achieved remission from the disease, indicating a reduction or absence of disease symptoms. It is essential for clinical documentation and billing to reflect the patient's current status accurately, ensuring appropriate treatment and follow-up care.

ICD-10 Code C93.01 – Clinical Definition and Explanation of Acute monoblastic/monocytic leukemia, in remission

Acute monoblastic/monocytic leukemia, in remission, is caused by genetic mutations leading to the uncontrolled proliferation of monoblasts or monocytic cells. This condition can progress rapidly and requires immediate medical attention to manage symptoms and prevent complications. Continuous monitoring is essential to ensure the patient remains in remission.

Key Clinical Features:

  • Presence of monocytic cells in blood and bone marrow.
  • Symptoms may include fatigue, fever, and bleeding tendencies.
  • Requires regular blood tests to monitor remission status.
  • Potential for relapse necessitates ongoing follow-up.

ICD-10 Code C93.01 for Acute monoblastic/monocytic leukemia, in remission – SOAP Notes & Clinical Use

ICD-10 Code C93.01 is utilized in SOAP notes to document the patient's remission status, guiding clinical assessments and treatment plans. It plays a crucial role in both acute and chronic care settings, ensuring that healthcare providers can track the patient's progress and adjust therapies as needed.

What Does ICD-10 Code C93.01 for Acute monoblastic/monocytic leukemia, in remission Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C93.01 connects subjective patient reports and objective clinical findings to a formal diagnosis of remission. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C93.01 – Acute monoblastic/monocytic leukemia, in remission

Management of Acute monoblastic/monocytic leukemia, in remission, requires a comprehensive approach to maintain remission and prevent complications.

Antibiotic Therapy:

  • Not typically indicated unless there is an infection; consider broad-spectrum antibiotics if needed.
  • First-line: Piperacillin-tazobactam for febrile neutropenia.
  • Alternative: Meropenem for resistant infections.
  • Duration: Typically 7-14 days based on clinical response.

Supportive Care:

  • Regular blood transfusions to manage anemia.
  • Growth factors (e.g., G-CSF) to stimulate white blood cell production.
  • Nutritional support to enhance recovery.
  • Psychosocial support for emotional well-being.

Infection Control:

  • Strict hand hygiene protocols to prevent infections.
  • Isolation precautions during neutropenic episodes.
  • Vaccination updates as per guidelines.
  • Monitoring for signs of infection regularly.

How to Document Symptoms of Acute monoblastic/monocytic leukemia, in remission (ICD-10 C93.01) in SOAP Notes

Subjective:

  • Patient reports fatigue and occasional night sweats.
  • Denies fever or recent infections.
  • History of easy bruising noted.
  • Patient expresses concern about potential relapse.

Objective:

  • Vital signs stable: BP 120/80, HR 72, Temp 98.6°F.
  • CBC shows normal white blood cell count.
  • Bone marrow biopsy indicates no evidence of leukemic cells.
  • Physical exam reveals no lymphadenopathy or splenomegaly.
card-topcard-bottom

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more
hipaa-icon

SOAP Note Guidelines for Diagnosing Acute monoblastic/monocytic leukemia, in remission (ICD-10 Code C93.01)

Assessment:

  • Diagnosis: Acute monoblastic/monocytic leukemia, in remission.
  • ICD-10 Code: C93.01.
  • Triggers: Previous chemotherapy and genetic predisposition.
  • Monitoring for potential relapse is essential.

Plan:

  • Continue regular follow-up appointments every 3 months.
  • Administer supportive care as needed.
  • Educate patient on signs of relapse and when to seek care.
  • Schedule next bone marrow biopsy in 6 months.

Treatment & Plan Section for ICD-10 Code C93.01 – Acute monoblastic/monocytic leukemia, in remission

  • Monitor blood counts regularly to assess remission status.
  • Administer growth factors as needed to support recovery.
  • Provide education on lifestyle modifications to enhance health.
  • Schedule follow-up visits to ensure ongoing management.

Using ICD-10 Code C93.01 for Acute monoblastic/monocytic leukemia, in remission in Billing & SOAP Note Compliance

  • Ensure accurate documentation of patient symptoms and treatment plans.
  • Use C93.01 in settings where remission status is confirmed.
  • Align treatment plans with clinical guidelines to support billing.
  • Include relevant CPT codes that correspond to services provided.

ICD-10 Code C93.01 in Medical Billing and Insurance for Acute monoblastic/monocytic leukemia, in remission

ICD-10 Code C93.01 is critical for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

  • Document all relevant patient history and treatment details to support claims.
  • Use C93.01 in conjunction with other codes reflecting the patient's overall health status.
  • Ensure compliance with payer guidelines for documentation.
  • Highlight any complications or comorbidities in the medical record.

Common CPT Pairings:

CPT CodeDescription
85025Complete blood count with differential.
88305Pathology examination of bone marrow.
96413Chemotherapy administration, intravenous.
99214Established patient office visit, moderate complexity.

Frequently Asked Questions

Common Questions About Using ICD-10 Code C93.01 for Acute monoblastic/monocytic leukemia, in remission

What does it mean for a patient to be in remission?

Being in remission means that the signs and symptoms of Acute monoblastic/monocytic leukemia have significantly decreased or are no longer detectable, indicating a positive response to treatment.

How often should patients with this diagnosis be monitored?

Patients in remission should be monitored regularly, typically every 3 months, to assess for any signs of relapse and to manage ongoing health needs.

Can Acute monoblastic/monocytic leukemia come back after remission?

Yes, there is a possibility of relapse after remission, which is why continuous monitoring and follow-up care are essential for early detection and intervention.

What are the common treatments for this condition?

Treatment may include supportive care, regular blood transfusions, and monitoring for infections, as well as potential re-initiation of chemotherapy if relapse occurs.

diamond-bg
diamond-bg

Get started with your 20 free notes

Sign up for free
main-logo

AI-aided Sudsy Shorthand for ink-free practices

support@soapsuds.io
hipaa-logo

Clinical Notes

SOAP notes

DAP notes

AI medical notes

© Copyright SOAPsuds 2025. All rights reserved